ASPI Company Profile and Key Details

Short-term trend indicators are bullishly aligned (SMA20 -0.41%, SMA50 -9.65%, SMA200 -29.58%). The stock’s 14-day RSI is 46.15 (neutral), while the ATR of 0.54 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -60.94% below its high and over 55.07% above its low. Average 10-day trading volume of 5.38 million shares is in line with the 3-month average of 4.97 million, indicating normal recent market interest.

Wall Street analysts project EPS growth of 6.2% annually over the next five years. Analyst sentiment is bullish. Analyst rating data shows there are 1 Strong Buy ratings, 3 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $13.00 to $11.00. The high target offers 110.7% upside. The low target suggests 78.28% downside. The mean target is $11.50. This offers 86.39% upside. ASP Isotopes Inc. Common Stock earnings surprise history is a consistent trend of beating forecasts. The quarter that ended May 20, 2026, missed forecasts by -21.43%. The prior quarter beat by 514.62%. Over the last six quarters, Apple has recorded several small beats. These include 0.0% in April 09, 2025.

ASP Isotopes Inc. Common Stock has 125.90 million shares outstanding. The public float is 95.85 million shares, elevated short interest at 20.00% of float. This equals 22.58 million shares. The short ratio is 4.27 days. Institutional investors hold 60.12% of the float. Insiders own 19.37%. Mann Paul Elliot holds 9.58 million shares, AK Jensen Investment Management Ltd has 6.57 million shares and Ainscow Robert has 2.28 million shares. Over the past six months, insider transactions show net selling. They sold 504.13 thousand shares across 9 transactions.

ASP Isotopes Inc. Common Stock last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$6.56. This means the shares are trading below this model’s fair value.

ASP Isotopes Inc. Common Stock (NASDAQ:ASPI) closed at $6.17 USD, losing -$0.18 (-2.83%) from the previous close of $6.35. The stock is currently mid-range between its 52-week high and low $3.92 and $14.49. With a market capitalization of about $512.71 million, ASP Isotopes Inc. Common Stock is classified as a small-cap and shows higher-than-market volatility (beta ~3.44). Key stats such as the average daily volume over the past year has been around 4.99 million shares, trading with heavier-than-usual volume. Headquartered in Washington, FL, ASP Isotopes Inc. Common Stock operates in the Basic Materials sector and the Chemicals industry. Led by CEO Paul Elliot Mann, the company employs approximately 136 people and listed since November 10, 2022. ASP Isotopes Inc. is an emerging advanced materials company, currently in its pre-commercial stage.

ASP Isotopes Inc. Common Stock trades at a P/E ratio of -2.9, slightly below the S&P 500 average, with a price-to-sales ratio of 18.59 and a price-to-book ratio of 2.52 suggesting the stock is closer to book value. The P/FCF stands at -7.61, also below market averages.

Our AI price prediction model suggests that ASP Isotopes Inc. Common Stock stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 8.1%, with price expected at $6.67 by July 10, 2026, within a range of $5.78 to $7.54 3-Month Outlook: Projected fall of -0.32%, reaching $6.15 by September 24, 2026, with a range of $5.82 to $6.43. 1-Year Outlook: Projected loss of -16.05%, with price at $5.18 by June 25, 2027, within a range of $0.00 to $5.17.

ASP Isotopes Inc. Common Stock (NASDAQ:ASPI) shares are up 35.89% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows ASP Isotopes Inc. Common Stock trading at a premium to the broader market with a P/E of -2.9. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $8.43, suggesting 36.63% upside. Our AI forecast model points to short-term strength (8.1% over two weeks), a medium-term fall (-0.32% over three months), and a longer-term loss (-16.05% over one year), with expected trading ranges indicating moderate volatility.